Circulating miRNAs in myasthenia gravis: miR-150-5p as a new potential biomarker

OBJECTIVE: Myasthenia gravis (MG) is a chronic autoimmune disorder where autoantibodies target the nicotinic acetylcholine receptors (AChR+) in about 85% of cases, in which the thymus is considered to play a pathogenic role. As there are no reliable biomarkers to monitor disease status in MG, we ana...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Punga, Tanel, Le Panse, Rozen, Andersson, Mats, Truffault, Frédérique, Berrih-Aknin, Sonia, Punga, Anna R
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BlackWell Publishing Ltd 2014
Pynciau:
Research Papers
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4207504/
https://ncbi.nlm.nih.gov/pubmed/25356381
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.24
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg